Saudi Family Physicians' Knowledge of Secondary Prevention of Heart Disease: A National Assessment Survey

被引:0
|
作者
Alzahrani, Samer [1 ]
Alosaimi, Muteb [1 ]
Malibarey, Waad Mohammad [2 ]
Alhumaidi, Adi Abdullatif [2 ]
Alhawaj, Ali Hassan M. [3 ]
Alsulami, Nawal Jabr [3 ]
Alsharari, Abdulrahman Saud [4 ]
Alyami, Abdullah Ayedh [4 ]
Alkhateeb, Ziyad Abdullateef [5 ]
Alqarni, Salem Mohammed [6 ]
Khalil, Daniyah Abdulahad [7 ]
Almusailhi, Jawaher Ahmad [8 ]
Alabdulali, Fatemah Salman [9 ]
Al-Rasheedi, Zuhour Salem [10 ]
机构
[1] Al Imam Muhammad ibn Saud Islamic Univ, Dept Family Med, Fac Med, Riyadh, Saudi Arabia
[2] Taif Univ, Fac Med, Dept Family Med, At Taif, Saudi Arabia
[3] Ibn Sina Coll, Fac Med, Dept Pediat Med, Jeddah, Saudi Arabia
[4] Jordan Univ Sci & Technol, Fac Med, Dept Family Med, Irbid, Jordan
[5] King Faisal Univ, Fac Med, Dept Family Med, Al Hufuf, Saudi Arabia
[6] King Khalid Univ, Fac Med, Dept Family Med, Abha, Saudi Arabia
[7] King Abdulaziz Univ, Fac Med, Dept Family Med, Jeddah, Saudi Arabia
[8] Imam Abdulrahman Bin Faisal Univ, Fac Med, Dept Family Med, Dammam, Saudi Arabia
[9] King Saud Univ, Fac Med, Dept Family Med, Riyadh, Saudi Arabia
[10] Qassim Univ, Fac Med, Dept Family Med, Buraydah, Saudi Arabia
关键词
coronary heart disease; physicians' knowledge; CORONARY-ARTERY-DISEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coronary heart disease is one of the major causes of health problem across the globe. Saudi Arabia has a high prevalence of the disease, especially among populations living in urban areas. The main risk factor evaluated for the prevalence of the disease includes age gender, body mass index, medical history, and behaviors. Effective prevention is dependent on physicians' awareness as well as familiarity with the guidelines for successful implementation. Research studies show, however, the existence of a gap between the understanding of these guidelines and clinical customs in preventing coronary heart disease. As a result, the Saudi population is considered to be at a high risk of an epidemic, calling for immediate action. The research focuses on assessing Saudi family physicians' knowledge of the guidelines in secondary prevention of coronary heart disease and linking it to the disease prevalence in the kingdom. The study established that there is generally poor knowledge of secondary prevention guidelines among Saudi family physicians. The finding was evident from the prescription of drugs with adverse effects to patients as well as poor guidelines on patient adherence to secondary prevention that is offered by the physicians.
引用
收藏
页码:54 / 59
页数:6
相关论文
共 50 条
  • [31] Physicians' Knowledge, Attitudes and Barriers Regarding Chronic Kidney Disease Diagnosis and Management in Saudi Arabia
    Al-Zaman, Naweed
    Alem, Alaa
    Alharbi, Ohood A.
    Abdullah, Ebtesam Ahmed
    Azouni, Duha W.
    Hammad, Raghad K.
    Alhejaily, Reem M.
    Albadrani, Muayad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [32] TREATMENT OF ELEVATED CHOLESTEROL PLASMA-LEVELS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    JOST, S
    LICHTLEN, PR
    ZEITSCHRIFT FUR KARDIOLOGIE, 1995, 84 (08): : 577 - 595
  • [33] A comparison of secondary prevention practice in poststroke and coronary heart disease patients
    Vanek, J.
    Mayer, O., Jr.
    Seidlerova, J.
    Bruthans, J.
    Kielbergerova, L.
    Wohlfahrt, P.
    Krajcoviechova, A.
    Filipovsky, J.
    Cifkova, R.
    PUBLIC HEALTH, 2016, 137 : 64 - 72
  • [34] Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease
    Nidorf, Stefan M.
    Layland, Jamie
    Robinson, Philip C.
    Patel, Sanjay
    Psaltis, Peter J.
    Thompson, Peter L.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 216 (08) : 385 - 387
  • [35] Illness Beliefs About Heart Disease and Adherence to Secondary Prevention Regimens
    Stafford, Lesley
    Jackson, Henry J.
    Berk, Michael
    PSYCHOSOMATIC MEDICINE, 2008, 70 (08): : 942 - 948
  • [36] Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
    Bubnova, M. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (08): : 97 - 107
  • [37] Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease
    A. Tavridou
    A. Efthimiadis
    I. Efthimiadis
    H. Paschalidou
    European Journal of Clinical Pharmacology, 2006, 62 : 485 - 489
  • [38] Age, sex, and secondary prevention of ischaemic heart disease in everyday practice
    Jankowski, Piotr
    Czarnecka, Danuta
    Wolfshaut-Wolak, Renata
    Lysek, Radoslaw
    Lukaszewska, Anna
    Surowiec, Slawomir
    Loster, Magdalena
    Bogacki, Piotr
    Bryniarska-Mirek, Ewa
    Grodecki, Janusz
    Nessler, Jadwiga
    Podolec, Piotr
    Kawecka-Jaszcz, Kalina
    Pajak, Andrzej
    KARDIOLOGIA POLSKA, 2013, 71 (12) : 1251 - 1259
  • [39] Gender differences in secondary prevention of coronary heart disease:: reasons to worry or not?
    Nilsson, P
    Brandström, H
    Lingfors, H
    Erhardt, L
    Hedbäck, B
    Israelsson, B
    Sjöberg, G
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (01) : 37 - 42
  • [40] Secondary Prevention in Coronary Heart Disease: Goal Achievement and Drug Prescribing
    Trude Giverhaug
    Christine Bruland
    Thor Trovik
    Pharmacy World and Science, 2005, 27 : 472 - 474